U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07197723) titled 'Study of How People Make Decisions About Prostate Cancer Risk' on Sept. 25.
Brief Summary: The purpose of this study is to learn how people with BRCA1/2 mutations respond to genetic risk modifier testing. The researchers will learn more about how people make choices about their health care, including about methods to screen for prostate cancer. Researchers are also doing this study to learn about how the genetic risk modifier test affects people's thoughts and feelings.
Study Start Date: Sept. 25
Study Type: OBSERVATIONAL
Condition:
High Risk Prostate Cancer
Intervention:
GENETIC: cheek (buccal) swab
swab sample in person or...